Neuren Pharmaceuticals Limited (NURPF) Discusses Share Buyback Program, Financial Position, and Development Strategy for NNZ-2591 Transcript
Source: SeekingAlpha
2026-02-12 03:14:22 ET
Neuren Pharmaceuticals Limited (NURPF) Discusses Share Buyback Program, Financial Position, and Development Strategy for NNZ-2591 February 11, 2026 6:30 PM EST...
Read the full article on Seeking Alpha
For further details see:
Neuren Pharmaceuticals Limited (NURPF) Discusses Share Buyback Program, Financial Position, and Development Strategy for NNZ-2591 Transcript
Neuren Pharms Ltd Ord
NASDAQ: NURPF
NURPF Trading
0.0% G/L:
$8.525 Last:
2,000 Volume:
$8.525 Open:
